NOVARTIS NNOVARTIS NNOVARTIS N

NOVARTIS N

No trades
See on Supercharts
Market capitalization
‪167.41 B‬CHF
‪13.34 B‬CHF
‪40.83 B‬CHF
‪1.75 B‬
Beta (1Y)
0.66

About NOVARTIS N

CEO
Vasant Narasimhan
Headquarters
Basel
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0012005267
FIGI
BBG00HCYS021
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOVN is 85.53 CHF — it has increased by 1.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange NOVARTIS N stocks are traded under the ticker NOVN.
NOVARTIS N is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
NOVN stock is 2.27% volatile and has beta coefficient of 0.66. Check out the list of the most volatile stocks — is NOVARTIS N there?
One year price forecast for NOVARTIS N has a max estimate of 110.88 CHF and a min estimate of 74.15 CHF.
NOVN earnings for the last quarter are 1.59 CHF per share, whereas the estimation was 1.53 CHF resulting in a 4.37% surprise. The estimated earnings for the next quarter are 1.39 CHF per share. See more details about NOVARTIS N earnings.
NOVARTIS N revenue for the last quarter amounts to ‪10.79 B‬ CHF despite the estimated figure of ‪11.37 B‬ CHF. In the next quarter revenue is expected to reach ‪10.01 B‬ CHF.
Yes, you can track NOVARTIS N financials in yearly and quarterly reports right on TradingView.
NOVN stock has fallen by 0.52% compared to the previous week, the month change is a 0.40% fall, over the last year NOVARTIS N has showed a 2.61% decrease.
NOVN net income for the last quarter is ‪7.52 B‬ CHF, while the quarter before that showed ‪1.56 B‬ CHF of net income which accounts for 383.56% change. Track more NOVARTIS N financial stats to get the full picture.
Today NOVARTIS N has the market capitalization of ‪167.34 B‬, it has increased by 0.76% over the last week.
Yes, NOVN dividends are paid annually. The last dividend per share was 3.30 CHF. As of today, Dividend Yield (TTM)% is 3.86%. Tracking NOVARTIS N dividends might help you take more informed decisions.
NOVARTIS N dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NOVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS N stock right from TradingView charts — choose your broker and connect to your account.
NOVN reached its all-time high on Feb 13, 2020 with the price of 96.38 CHF, and its all-time low was 34.40 CHF and was reached on Aug 11, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS N on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS N technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS N stock shows the neutral signal. See more of NOVARTIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVARTIS N future price: according to them, NOVN price has a max estimate of 110.88 CHF and a min estimate of 74.15 CHF. Read a more detailed NOVARTIS N forecast: see what analysts think of NOVARTIS N and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS N EBITDA is ‪19.31 B‬ CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS N financial statements.